Clinical Trial Update: Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation [Phase 2]

View source ↗

Summary

A Phase 2 study on characterizing severe mood dysregulation and sequential pharmacotherapy has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disruptive Mood Dysregulation Disorder

Snippet

Sponsor: University of California, Los Angeles | Conditions: Severe Mood Dysregulation | Phase 2 | Status: COMPLETED | Results posted: 2018-02-26